ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$6.32
+0.03 (+0.48%)
Financial Highlights (FY 2026)
Revenue
55.16B
Net Income
-136,646,939
Gross Margin
-98.8%
Profit Margin
-397.8%
Rev Growth
-44.7%
D/E Ratio
0.69
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -98.8% -98.8% 64.9% 64.9%
Operating Margin -418.8% -376.9% 2.0% 1.9%
Profit Margin -397.8% -377.9% 1.6% 1.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 55.16B 99.69B 656.40M 699.53M
Gross Profit -54,476,245,613 -98,456,977,431 425.96M 453.94M
Operating Income -230,994,505,623 -375,736,589,663 13.43M 13.07M
Net Income -136,646,939 -222,270,459 10.36M 12.63M
Gross Margin -98.8% -98.8% 64.9% 64.9%
Operating Margin -418.8% -376.9% 2.0% 1.9%
Profit Margin -397.8% -377.9% 1.6% 1.8%
Rev Growth -44.7% -44.7% +1.9% +12.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 142.66M 142.66M 15.37M 15.24M
Total Equity 206.18M 206.18M 127.45M 128.08M
D/E Ratio 0.69 0.69 0.12 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -137,235,606 -235,629,542 18.53M 18.96M
Free Cash Flow — — 6.70M 12.14M